➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKinsey
Baxter
Colorcon
Harvard Business School

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Patent Applications for citalopram hydrobromide

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Patent Applications for citalopram hydrobromide

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial Use of sulfamate derivatives for treating impulse control disorders 2000-02-18 Patented Case 2001-11-09
  Start Trial   Start Trial METHODS FOR TREATING OR PREVENTING FIBROMYALGIA USING VERY LOW DOSES OF CYCLOBENZAPRINE 2001-06-27 Patented Case 2003-03-12
  Start Trial   Start Trial CITALOPRAM HYDROBROMIDE CRYSTAL AND METHOD FOR CRYSTALLIZATION THEREOF 2001-04-02 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2014-01-20
  Start Trial   Start Trial METHODS OF USING SIBUTRAMINE IN COMBINATION WITH A PHOSPHODIESTERASE INHIBITOR TO TREAT SEXUAL DYSFUNCTION 2001-01-29 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2010-12-06
  Start Trial   Start Trial METHODS OF INHIBITING PLATELET ACTIVATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS 2001-03-12 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2011-05-23
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Johnson and Johnson
McKesson
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.